Mustafa Diken speaks at the Institute for Chemical Immunology in Amsterdam

Mainz, March 16, 2018 –  The Dutch Society for Immunology (NVVI) is hosting the 4th Chemical Immunology Conference today in Amsterdam.

The meeting aims to cover the broad diversity of chemical immunology and some of the most exciting areas of research to have emerged.

TRON’s Mustafa Diken kicks off the day with his plenary, “mRNA as a versatile platform for cancer vaccines.”

View the entire program on the NVVI’s website.